Skip to content

Development and Validation of AI-Based Endoscopic Grading System for Gastric Mucosal Intestinal Metaplasia

Development and Validation of AI-Based Endoscopic Grading System for Gastric Mucosal Intestinal Metaplasia

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600128161
Enrollment
Unknown
Registered
2026-07-15
Start date
2026-07-20
Completion date
Unknown
Last updated
2026-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intestinal metaplasia of the gastric mucosa

Interventions

Index test:AI in diagnosing intestinal metaplasia by gastroscopy

Sponsors

Zhejiang Provincial Hospital of TCM
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Age: 40-75 years old, undergoing gastroduodenoscopy and NBI mode examination 2. Agree to undergo pathological examination of gastric mucosal biopsy (in accordance with clinical guidelines). Gastric mucosal biopsy is performed on patients who have obtained gastric mucosa according to the OGLM classification in the large curvature of the antrum, small curvature of the antrum, large curvature of the gastric body, small curvature of the gastric body, and gastric Angle 3. Patients who underwent EGGIM scoring during gastroscopy and had NBI images of the large curvature of the antrum, small curvature of the antrum, large curvature of the gastric body, small curvature of the gastric body, and gastric Angle retained 4. For prospective collection, an informed consent form was signed before the examination (for retrospective collection, an application for exemption from informed consent has been made)

Exclusion criteria

Exclusion criteria: 1. Severe heart, brain, lung or kidney dysfunction or mental illness that makes it impossible to tolerate gastroscopy 2. Previously underwent gastric surgery (such as gastrectomy, gastrointestinal anastomosis, etc.) 3. Active upper gastrointestinal bleeding affects endoscopic observation 4. Pregnant or lactating women who are undergoing anticoagulant therapy and cannot suspend it are known to have gastric cancer or other gastric malignancies

Design outcomes

Primary

MeasureTime frame
Accuracy;Specificity;Sensitivity;The area under the receiver operating characteristic curve of EGGIM diagnosed by AI;

Countries

China

Contacts

Public ContactLv Bin

Zhejiang Provincial Hospital of TCM

lvbin@medmail.com.cn+86 571 85463739

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 23, 2026